Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis

By sjmartinez • October 4, 2022

Ferrada MA, Savic S, Cardona DO, Collins JC, Alessi H, Gutierrez-Rodrigues F, Kumar DBU, Wilson L, Goodspeed W, Topilow JS, Paik JJ, Poulter JA, Kermani TA, Koster MJ, Warrington KJ, Cargo C, Tattersall RS, Duncan CJA, Cantor A, Hoffmann P, Payne EM, Bonnekoh H, Krause K, Cowen EW, Calvo KR, Patel BA, Ombrello AK, Kastner DL, Young NS, Werner A, Grayson PC, Beck DB. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis. Blood. 2022 Sep 29;140(13):1496-1506. doi: 10.1182/blood.2022016985. PMID: 35793467.

Tags: Rheumatology

Interleukin-6 inhibition for Takayasu’s arteritis: before or after tumour necrosis factor inhibitors?

Kermani TA, Warrington KJ. Interleukin-6 inhibition for Takayasu's arteritis: before or after tumour necrosis factor inhibitors? Clin Exp Rheumatol. 2025 Mar 25. doi: 10.55563/clinexprheumatol/2acgxz. Epub[...]

The effect of hydroxychloroquine on activities of daily living and hand function in systemic sclerosis: results from an analysis of the EUSTAR cohort

Bellando-Randone S, Wilhalme H, Bruni C, Czirjak L, Distler O, Allanore Y, Cuomo G, Denton C, Del Galdo F, Gheorghiu AM, Riccieri V, Walker U,[...]

The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms

Solomon DH, Paudel M, Chitineni S, Fernandes A, Pham T, Billa S, Yokose C, Tan K, Dedier JJ, Dubreuil MD, Fitzgerald JD, Hodder SL, Neogi[...]